Drug maker Wockhardt said on Friday that it partnered with Enso Healthcare, an aggregator for Russian Direct Investment Fund (RDIF) for its...

The Mumbai-based firm has entered into an agreement with Enso and Human Vaccine LLC , a wholly owned unit of the management company of RDIF...

In September 2020, the company partnered with RDIF to conduct the clinical trials of Sputnik V and distribute the vaccine in India. The Hyd...

The government initiated this review as local manufacturers are facing challenges in producing the second dose of the vaccine — unlike in o...

Ever since the government started its vaccination drive in January this year, it has been using Serum Institute of India's (SII) Covishield...

"We are motivated to serve patients in every possible way and with utmost urgency. This is reflected in the multiple collaborations we have...

Dr Reddy's which had received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for pilo...

The company has entered into a three-year agreement with Dr Reddy's Laboratories Limited (DRL) for the production of Sputnik V vaccine for ...

"The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three year definitive agreement with Dr...

Dr Reddy's Laboratories on May 14 soft-launched imported COVID-19 vaccine Sputnik V vaccine which is priced at Rs948, with five per cent GS...

Sputnik V was developed by Russia’s Gamaleya National Research Institute of Epidemiology and Microbiology with the backing of Russia’s sove...

The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) on Monday took up the application of Dr Reddy...

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint ...

Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually.

Stelis' pact with the Russian Direct Investment Fund (RDIF) follows similar deals struck by Indian pharmaceutical firms Gland Pharma and He...

If approved Sputnik would become the first non-Western coronavirus jab to be certified for use across the 27-nation bloc.

Countries in the region have been particularly hard hit by the virus and find themselves torn between a readily available jab from their ol...